Posted inGenetics How the Inflammatory Process Is Influenced by the Circadian Rhythm December 18, 2024 There are various studies that have explored the role of the body’s circadian rhythm in regulating immune activity. Disruptions in…
Posted inBiotechnology Novo Nordisk taps Photys for $186M cardiometabolic collab December 17, 2024 With Novo Nordisk’s name already synonymous with treatments for diabetes and obesity, the Danish drugmaker has been making a concerted…
Posted inBiotechnology Novo Holdings leads SiteOne’s $100M series C for non-opioid pain treatments December 17, 2024 SiteOne Therapeutics is powering up with $100 million to advance its early pipeline of non-opioid therapeutics that target the peripheral…
Posted inGenetics Ketamine Keeps Zebrafish from Giving up by Overstimulating Astroglia December 17, 2024 The anesthetic ketamine could be a game changer for treating severe depression, but there are still many questions about how…
Posted inMedical Technology BD, Babson Diagnostics expand fingertip blood draws to urgent care clinics, doctors’ offices December 17, 2024 Longtime partners in simplifying blood sample collection and testing, BD and Babson Diagnostics are now making their miniaturized approach available…
Posted inMedical Technology Dexcom taps generative AI lifestyle tips for its Stelo glucose sensor December 17, 2024 Dexcom has launched a generative AI platform aimed at providing personalized lifestyle tips to the users of its over-the-counter wearable…
Posted inBiotechnology Sanofi, Teva look to ‘next frontier’ in IBD treatment after TL1A antibody hits mark in midstage trial December 17, 2024 As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and Teva…
Posted inBiotechnology Biomea’s diabetes drug improves glucose control 3 months after FDA hold lifted December 17, 2024 Three months after Biomea Fusion’s menin inhibitor was released from a clinical hold, the company has claimed a win in…
Posted inBiotechnology Cash-strapped Portage finds hope in sale of lead asset, subsidiary to Immunova December 17, 2024 After spending most of the year hunting for options to stay afloat, cash-strapped Portage Biotech appears to have found salvation…
Posted inBiotechnology Fresh off $120M raise, AI-powered Terray is teaming up with Gilead in multi-pronged R&D pact December 17, 2024 Terray is ending the year on a high. Just two short months ago the biotech came out with a healthy…